Sara Y. Tartof

Kaiser Permanente Southern California - Department of Research & Evaluation

Pasadena, CA

United States

SCHOLARLY PAPERS

8

DOWNLOADS
Rank 10,418

SSRN RANKINGS

Top 10,418

in Total Papers Downloads

8,672

SSRN CITATIONS
Rank 30,822

SSRN RANKINGS

Top 30,822

in Total Papers Citations

37

CROSSREF CITATIONS

0

Scholarly Papers (8)

1.

Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study

Number of pages: 40 Posted: 23 Aug 2021
Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente - Southern California Kaiser Permanente Medical Group, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California, Kaiser Permanente - Southern California Kaiser Permanente Medical Group, Kaiser Permanente - Kaiser Permanente Center for Integrated Health Care Research, Kaiser Permanente Southern California - Department of Research & Evaluation, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs and Pfizer, Inc.
Downloads 5,583 (2,898)

Abstract:

Loading...

2.

BNT162b2 (Pfizer–Biontech) mRNA COVID-19 Vaccine Against Omicron-Related Hospital and Emergency Department Admission in a Large US Health System: A Test-Negative Design

Number of pages: 25 Posted: 18 Jan 2022
Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, Pfizer, Inc., Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs and Pfizer, Inc.
Downloads 2,112 (14,348)

Abstract:

Loading...

omicron, effectiveness, waning, booster, third dose, BNT162b2, SARS-CoV-2, COVID-19, United States, test-negative, kaiser

3.

BNT162b2 Effectiveness and Durability Against BA.1 and BA.2 Hospital and Emergency Department Admissions in a Large US Health System: A Test-Negative Design

Number of pages: 25 Posted: 30 Jun 2022
Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, Pfizer, Inc., Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs and Pfizer, Inc.
Downloads 386 (146,940)
Citation 1

Abstract:

Loading...

BA.2, BA.1, omicron, effectiveness, BNT162b2, SARS-CoV-2, COVID-19, United States, test-negative, Kaiser Permanente, real-world

4.

Effectiveness of a Third Dose of BNT162b2 mRNA COVID-19 Vaccine in a Large US Health System: A Retrospective Cohort Study

Number of pages: 35 Posted: 21 Dec 2021
Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, Pfizer, Inc., Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente - Kaiser Permanente Center for Integrated Health Care Research, Kaiser Permanente Southern California, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs and Pfizer, Inc.
Downloads 384 (147,769)
Citation 5

Abstract:

Loading...

effectiveness, waning, booster, third dose, BNT162b2, SARS-CoV-2, COVID-19, United States, cohort, delta

5.

Lack of Physical Activity Associated with Higher Rates of Severe COVID-19 Outcomes

Number of pages: 16 Posted: 21 Jan 2021
Kaiser Permanente Medical Center - Department of Family and Sports Medicine, Southern California Kaiser Permanente Medical Group - Department of Research and Evaluation, Kaiser Permanente Southern California - Department of Research & Evaluation, University of California, San Diego (UCSD) - Herbert Wertheim School of Public Health and Human Longevity Science, Kaiser Permanente Medical Center - Department of Family and Sports Medicine, Southern California Kaiser Permanente Medical Group - Department of Research and Evaluation, Pomona College - Economics Department and Kaiser Permanente - Southern California Kaiser Permanente Medical Group
Downloads 98 (506,933)

Abstract:

Loading...

6.

Natural Language Processing for Improved COVID-19 Characterization: Evidence from More than 350,000 Patients in a Large Integrated Health Care System

Number of pages: 19 Posted: 05 Apr 2022
Government of the United States of America - Centers for Disease Control and Prevention (CDC), Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Northern California, Genentech, Inc. - San Francisco, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California and Kaiser Permanente Southern California
Downloads 46 (754,734)

Abstract:

Loading...

Natural language processing, Public health surveillance, SARS-CoV-2, artificial intelligence

7.

Safety of Tetanus, Diphtheria, Acellular Pertussis (Tdap) Vaccination During Pregnancy

Number of pages: 37 Posted: 30 Nov 2021
Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California - Department of Research & Evaluation, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Slaoui Center for Vaccines Research, GSK, GSK, GSK, GSK, GSK, GSK, GSK, GSK, GSK, GSK and Kaiser Permanente Southern California
Downloads 35 (835,575)

Abstract:

Loading...

vaccine safety, Tdap vaccine, maternal immunization, pregnancy, observational study

8.

Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies

Number of pages: 30 Posted: 18 Feb 2022
Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California, Kaiser Permanente Southern California - Department of Research & Evaluation, Slaoui Center for Vaccines Research, GSK, GSK, GSK, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK, GSK, GSK, GSK, GSK and Kaiser Permanente Southern California
Downloads 28 (895,358)

Abstract:

Loading...

VACCINE SAFETY, diphtheria-tetanus-acellular pertussis vaccine, congenital anomalies, observational study